Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Heska Corporation    HSKA

HESKA CORPORATION

(HSKA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Summary
  • In view of fundamental criteria, the company is among low performers as far as mid or long-term investment strategy is concerned.
  • The company has poor fundamentals for a short-term investment strategy.
Strengths
  • Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
  • Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
  • Over the last twelve months, the sales forecast has been frequently revised upwards.
  • The stock is in a well-established, long-term rising trend above the technical support level at 81.53 USD
Weaknesses
  • Stock prices approach a strong long-term resistance in weekly data at USD 127.49.
  • The stock is close to a major daily resistance at USD 129.18, which should be gotten rid of so as to gain new appreciation potential.
  • Low profitability weakens the company.
  • Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
  • The group usually releases earnings worse than estimated.
  • For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
  • For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
Ratings chart
Sector Medical Equipment, Supplies & Distribution
1st jan.Capitalisation (M$)Investor Rating
HESKA CORPORATION30.29%1 182
ABBOTT LABORATORIES24.59%191 805
MEDTRONIC PLC0.22%152 480
STRYKER CORPORATION11.17%87 710
BECTON, DICKINSON AND COMPA..-13.65%68 111
HOYA CORPORATION33.11%49 894
IDEXX LABORATORIES, INC.76.53%39 322
BAXTER INTERNATIONAL INC.-9.03%38 858
ALIGN TECHNOLOGY, INC.72.48%37 950
SARTORIUS STEDIM BIOTECH105.15%33 382
COLOPLAST A/S12.73%31 802
ALCON INC.5.80%31 298
ZIMMER BIOMET HOLDINGS-0.37%30 909
DEXCOM, INC.46.15%30 698
TERUMO CORPORATION6.74%30 026
SYSMEX CORPORATION46.73%21 881
More Results
Financials (USD)
Sales 2020 186 M - -
Net income 2020 -18,8 M - -
Net Debt 2020 - - -
P/E ratio 2020 -57,2x
Yield 2020 -
Capitalization 1 182 M 1 182 M -
Capi. / Sales 2020 6,35x
Capi. / Sales 2021 5,37x
Nbr of Employees 386
Free-Float 93,8%
Upcoming event on HESKA CORPORATION
Notations Surperformance©
  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation -
Finances -
Profitability
Earnings quality
Business Predictability
P/E ratio -
Potential
Yield -
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes